Versant Venture Management as of June 30, 2018
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 9 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 66.2 | $212M | 3.6M | 58.76 | |
| Audentes Therapeutics | 14.4 | $46M | 1.2M | 38.21 | |
| Ocular Therapeutix (OCUL) | 4.7 | $15M | 2.2M | 6.75 | |
| Cymabay Therapeutics | 4.4 | $14M | 1.0M | 13.42 | |
| Achaogen | 3.5 | $11M | 1.3M | 8.66 | |
| Immune Design | 3.1 | $10M | 2.2M | 4.55 | |
| Second Sight Med Prods | 2.3 | $7.5M | 4.5M | 1.66 | |
| Clovis Oncology | 1.4 | $4.6M | 102k | 45.47 | |
| Opgen | 0.1 | $182k | 102k | 1.78 |
